Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Adam D. Cohen, MD

Adam D. Cohen, MD Physician

Director, Myeloma Immunotherapy Assistant Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Cohen is a Penn Medicine employed physician.

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties

Specialty:

  • Hematology
  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 2007
  • Medical Oncology, 2005

Clinical Expertise:

  • Autologous Stem Cell Transplantation
  • Lymphoma
  • Multiple Myeloma
  • Waldenstrom Macroglobulinemia (WM)

Description of Clinical Expertise

Multiple Myeloma
Amyloidosis
POEMS syndrome
Monoclonal gammopathies
Waldenstrom's Macroglobulinemia

Practice Locations and Appointments

  • Abramson Cancer Center

    Perelman Center for Advanced Medicine West Pavilion, 4th Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-7366 (PENN)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: University of Pennsylvania School of Medicine
Residency: Hospital of the University of Pennsylvania
Fellowship: Memorial Sloan-Kettering Cancer Center

Memberships

16th International Myeloma Workshop, International American Association for Cancer Research, National American Society for Blood and Marrow Transplantation, National American Society of Clinical Oncology, National American Society of Hematology, National Amyloidosis Support Group, Philadelphia Chapter, Local Association for International Cancer Research, International Eastern Cooperative Oncology Group, National Independent Response Adjudication Committee (IRAC), ARRAY-520-215 trial (NCT02092922), International Independent Response Adjudication Committee (IRAC), ACE-MM-102 trial (NCT01997840) , International Independent Response Adjudication Committee, MM-020 trial (NCT00689936), International International Myeloma Society, International Managing Myeloma (educational resource), National National Comprehensive Cancer Network, National Society for Immunotherapy of Cancer (SITC) , International The Myeloma Beacon (a patient advocacy website), National

Hospital Affiliation

Dr. Cohen is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

Cancer immunotherapy
Vaccines
Cellular therapy
Phase I trials

Selected Publications:

Raje N, Faber E, Richardson P, Schiller G, Hohl R, Cohen AD, Forero A, Carpenter S, Nguyen T, Conti I, Kaiser C, Cronier D, Wooldridge J, Anderson K: Phase 1 study of tabalumab, a human anti-B-cell activating factor antibody, and bortezomib in patients with relapsed/refractory multiple myeloma Clinical Cancer Research 22 : 5688-5695,2016.

Adam D. Cohen, Alfred L. Garfall, Edward A Stadtmauer, Simon Francis Lacey, Eric Lancaster, Dan T. Vogl, Karen Dengel, David E Ambrose, Fang Chen, Gabriela Plesa, Irina Kulikovskaya, Vanessa E Gonzalez, Minnal Gupta, Regina M Young, Tenesia Carey, Regina Ferthio, Brendan M. Weiss, Celeste Richardson, Randi E. Isaacs, J. Joseph Melenhorst, Bruce L. Levine, Carl H June, Michael C. Milone: B-Cell Maturation Antigen (BCMA)-Specific Chimeric Antigen Receptor T Cells (CART-BCMA) for Multiple Myeloma (MM): Initial Safety and Efficacy from a Phase I Study Blood (ASH Annual Meeting) 128 : #1147,2016.

Muzaffar H. Qazilbash, Edward A Stadtmauer, Veera Baladandayuthapani, Heather Lin, Beryl M. Tross, Medhavi Honhar, Soung-Chul Cha, Kunhwa Kim, Sheetal S Rao, Michael Popescu, Nina Shah, Qaiser Bashir, Krina Patel, Elizabeth J. Shpall, Donna M. Weber, Sheeba K. Thomas, Jatin J. Shah, Robert Z. Orlowski, Naseem DS Kerr, Alfred L. Garfall, Adam D. Cohen, Karen Dengel, Carl H June, Richard E. Champlin, Larry Kwak: Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation Blood (ASH Annual Meeting) 128 : #4548,2016.

Lesokhin AM, Ansell SM, Armand P, Scott EC, Halwani A, Gutierrez M, Millenson MM, Cohen AD, Schuster SJ, Lebovic D, Dhodapkar M, Avigan D, Chapuy B, Ligon AH, Freeman GJ, Rodig SJ, Cattry D, Zhu L, Grosso JF, Shipp MA, Borello I, Timmerman J.: Safety, Pharmacokinetics, Immunoregulatory and Preliminary Antitumor Activity of Nivolumab in Patients with Relapsed or Refractory Hematologic Malignancy Journal of Clinical Oncology 34 : 2698-2704,2016.

Adam D. Cohen, Rakesh Popat, Suzanne Trudel, Paul G Richardson, Ed N. Libby III, Nikoletta Lendvai, Larry D. Anderson Jr., Heather J. Sutherland, Stephen DeWall, Catherine E Ellis, Zangdong He, Jolly Mazumdar, Catherine Wang, Joanna B. Opalinska, Peter M. Voorhees: First in Human Study with GSK2857916, an Antibody Drug Conjugated to Microtubule-Disrupting Agent Directed Against B-Cell Maturation Antigen (BCMA) in Patients with Relapsed/Refractory Multiple Myeloma (MM): Results from Study BMA117159 Part 1 Dose Escalation Blood (ASH Annual Meeting) 128 : #1148,2016.

Adam D. Cohen, Heather Landau, Emma C. Scott, Michaela Liedtke, Jonathan L. Kaufman, Michael Rosenzweig, Cristina Gasparetto, David H. Vesole, Vaishali Sanchorawala, Suzanne Lentzsch, Christina L. Gomes, Raymond L. Comenzo, Brian G.M. Durie: Safety and Efficacy of Carfilzomib (CFZ) in Previously-Treated Systemic Light-Chain (AL) Amyloidosis Blood (ASH Annual Meeting) 128 : #645,2016.

Brendan M. Weiss, Sigrun H Lund, Magnus Bjorkholm, Adam D. Cohen, Laura Dember, Ola Landgren, Sigurdur Y Kristinsson: Improved Survival in AL Amyloidosis: A Population-Based Study on 1,430 Patients Diagnosed in Sweden 1995-2013 Blood (ASH Annual Meeting) 128 : #4448,2016.

Alex Ganetsky, Noelle V Frey, Alison W Loren, Elizabeth O. Hexner, James K Mangan, Saar I Gill, Selina Luger, Adam D. Cohen, Daria V Babushok, Edward A Stadtmauer, Jacqueline Smith, William R. Drobyski, Sarah K Kraus, Colleen Timlin, David L. Porter: Tocilizumab Is Highly Active for Severe Steroid-Refractory Acute Graft-Versus-Host Disease of the Gastrointestinal Tract Blood (ASH Annual Meeting) 128 : #2245,2016.

Alfred L. Garfall, Eric Lancaster, Edward A Stadtmauer, Simon F. Lacey, Karen Dengel, David E Ambrose, Fang Chen, Minnal Gupta, Irina Kulikovskaya, Dan T. Vogl, Gabriela Plesa, Brendan M Weiss, Regina Ferthio, Celeste Richardson, Jan Joseph Melenhorst, Bruce L Levine, Carl H June, Michael Milone, Adam D. Cohen: Posterior Reversible Encephalopathy Syndrome (PRES) after Infusion of Anti-Bcma CAR T Cells (CART-BCMA) for Multiple Myeloma: Successful Treatment with Cyclophosphamide Blood (ASH Annual Meeting) 128 : #5702,2016.

Lilly Wilson, Adam D. Cohen, Brendan M. Weiss, Dan T. Vogl, Alfred L. Garfall, Donna L. Capozzi, Patricia Mangan, Mary Sanchez, Colleen Erb, Edward Stadtmauer: Pembrolizumab in Combination with Pomalidomide and Dexamethasone (PEMBRO/POM/DEX) for Pomalidomide Exposed Relapsed or Refractory Multiple Myeloma Blood (ASH Annual Meeting) 128 : #2119,2016.

Academic Contact Info

Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-154
3400 Civic Center Blvd


Philadelphia, PA 19104
Phone: 215-615-5853
Fax: 215-615-5887
Patient appointments: 800-789-7366 (PENN)